(Q43908983)

English

Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled corticosteroids

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled corticosteroids (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

W James Metzger

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Frank C Hampel

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Mark Sugar

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Journal of Asthma

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

65-75

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Refractory asthma, Part 1: Epidemiology, pathophysiology, pharmacologic interventions

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Inhaled glucocorticoids for asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Importance of the inhalation device on the effect of budesonide

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

A Comparison of the Effects of bid and qid Dosing on Compliance with Inhaled Flunisolide

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Interpreting treatment effects in randomised trials

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Assessing the minimal important difference in symptoms: a comparison of two techniques.

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Nonadherence in asthmatic patients: is there a solution to the problem?

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Measuring compliance with inhaled medication in asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Airway remodelling takes place in asthma--what are the clinical implications?

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Compliance with inhaled therapy and morbidity from asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Maintaining long-term control of blood pressure: The role of improved compliance

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Once-daily versus twice-daily dosing of theophylline. A decision analysis approach to evaluating theophylline blood levels and compliance

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Once-daily budesonide in mild asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Psychological factors associated with medication nonadherence in asthmatic children

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120000808

21 January 2018

Identifiers

10.1081/JAS-120000808

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43908983&oldid=2104330950"